APP and Alzheimer disease: Based on the aging comorbidity and pathology of AD, SAMP8 mice and APP/PSI double transgenic rats are better to mimic the characteristics of AD [71]; however, the weaknesses are a longer preparation time and a higher cost, which to a great extent limits their current use in practice.